Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/IMMUNEONCO-BIOPHARMACEUTI-158607346/news/ImmuneOnco-Biopharmaceuticals-Shanghai-Inc-erhalt-eine-IND-Zulassung-Investigational-New-Drug-45258053/?utm_source=whatsapp&utm_medium=social&utm_campaign=share